Founder of India’s largest pharmaceutical company - Dilip Shanghvi is among the country's richest person
According to Forbes, as of 26 July 2022, Dilip Shanghvi has a net worth of Rs 1,14,868 crore.
Dilip Shanghvi is the founder of India’s largest pharmaceutical company, Sun Pharmaceuticals Industries Ltd. In 2016, he was awarded the ‘Padma Shri’ civilian honour by the Government of India.
Sun Pharmaceutical Industries Ltd manufactures, develops, and markets a diverse range of branded and generic formulations as well as Active Pharma Ingredients (APIs). The company and its subsidiaries have about 43 manufacturing facilities around the world, as well as trading and other ancillary and related activities that spread over the international market.
The company’s revenue can be divided into 5 parts - India branded formulations (31% of the revenue), US formulations (30%), emerging markets (18%), rest of the world (ROW) (15%), and API & others (6%).
The company is the 9th largest pharma player in US generic market. About India branded generic business, the company is the market leader with a market share of 8.2%, operating under 29 different brands. In emerging markets, Romania, Russia, South Africa, Brazil, and Mexico are the main market for the company. Western Europe, Canada, Japan, Israel, and A&NZ are the major markets under the ROW segment.
Talking about company financials, the 3-year sales and net profit growth numbers look attractive for the company which stood at 10% and 24%, respectively. While, the 10-year number also remains decent at 17% and 10%, respectively. As per the March period ending, the company has an ROE, ROCE, and dividend yield of 14%, 18.4%, and 0.81%, respectively.
The company has a market capitalization of Rs 209870 crore, and its shares are trading at a PE multiple of 31.7x. Talking about the shareholding pattern, about 54.48% stake is owned by the promoters, FIIs and DIIs together hold 34.61%, and the rest 10.91% stake is held by non-institutional investors.
On July 26, at 11:55 am, the stock is trading at Rs 867.15. The stock has a 52-week high and low of Rs 967 and Rs 673, respectively.
About the Author
DisclaimerInvestment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial. Also, The
Start Investing Now!
Open Free Demat Account in 5 mins